Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 20,531 | 31,937 | 13,728 | 6,053 | 1,629 |
| Gross Profit | 20,531 | 31,937 | 13,728 | 6,053 | 1,629 |
| Operating Expenses | 161,453 | 145,664 | 133,661 | 103,241 | 36,941 |
| Operating Income | -140,922 | -113,727 | -119,933 | -97,188 | -35,312 |
| Interest Expense | 137 | -328 | 978 | -62 | 143 |
| Other Income | 7,313 | 3,445 | 587 | -57 | -37,445 |
| Pre-tax Income | -133,746 | -109,954 | -120,324 | -97,183 | -72,900 |
| Net Income Continuous | -133,746 | -109,954 | -120,324 | -97,183 | -72,900 |
| Net Income | $-133,746 | $-109,954 | $-120,324 | $-97,183 | $-72,900 |
| EPS Basic Total Ops | -2.68 | -2.33 | -2.98 | -3.02 | -28.55 |
| EPS Basic Continuous Ops | -2.68 | -2.33 | -2.98 | -3.02 | -28.40 |
| EPS Diluted Total Ops | -2.68 | -2.33 | -2.98 | -3.02 | -28.55 |
| EPS Diluted Continuous Ops | -2.68 | -2.33 | -2.98 | -3.02 | -28.40 |
| EPS Diluted Before Non-Recurring Items | -2.68 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-138,092 | $-110,473 | $-117,250 | $-95,986 | $-34,841 |